ANDEMBRY
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ANDEMBRY, covering 2025-03-11 to 2026-08-19. Get the full timeline:
Most recent: EMA Authorised: Andembry (garadacimab) — CSL Behring GmbH
3 regulatory and trial events tracked for ANDEMBRY, covering 2025-03-11 to 2026-08-19. Get the full timeline:
Most recent: EMA Authorised: Andembry (garadacimab) — CSL Behring GmbH